Peptide Knowledge Base · Longevity
Vilon: what it is, what the evidence says, and its real status
A Khavinson-school dipeptide 'bioregulator' claimed for immune and longevity support, minimal independent evidence.
Short version: another Khavinson 'bioregulator,' this one pitched for immune and aging support. Minimal independent data; long-tail, education only.
Can you actually get it?
Plain-English verdict: Education only.
Regulatory status: Research-only · Education only.
Not offered, education only. Vilon is a Khavinson-class dipeptide with Russian-origin claims and minimal independent validation. Not FDA-approved, not available.
How does Vilon work?
A dipeptide proposed by the Khavinson school as an immune/longevity 'bioregulator' of gene expression.
What it does — and what it does not do
What it does: Claimed in Russian-origin work to support immune function and aging.
What it does not do: It is not independently validated, not approved, and not available.
How honest is the evidence?
Evidence grade D — Russian-origin claims; minimal independent replication. Read our grading methodology for what each grade means.
What we still don't know: Independent replication is minimal; outcomes unconfirmed.
WADA status: Not prohibited.
How it is taken
No established human clinical dosing; research-stage.
Who should not take it
Not characterized in independent practice; no established safety profile.
Sources
Khavinson peptide-bioregulator literature (limited independent replication)
Compounded medications are not FDA-approved. We keep two signals separate and never collapse them: whether you can get something, and what the rule currently says. See the live FDA Peptide Tracker or the knowledge base.
Last reviewed 2026-08-11 · Peptós.LIFE · Not medical advice.